معرفی
Kelly Martinovich is a Research Fellow at the Personalised Medicine Centre within the Health Futures Institute at Murdoch University. She completed her PhD in 2021 at the University of Western Australia and has been recognized with multiple awards for academic excellence, including the Inaugural Innovation Fellowship from the WA government in 2022.
Her educational background includes:
- Bachelor of Science (2005-2008), Murdoch University
- Bachelor in Medical Science (Honors, 2009), University of Western Australia
- Doctor of Philosophy (2017-2021), The University of Western Australia, School of Biomedical Sciences
Kelly's research is centered on advancing therapeutics development, with a focus on antisense oligonucleotides for correcting CFTR function in Cystic Fibrosis. Her expertise extends to Airway Diseases, Infectious Diseases, and Cardiovascular Diseases, leveraging cell and molecular biology methodologies to drive novel discoveries in personalized medicine.
She has been awarded:
- Inaugural Innovation Fellowship (WA government, 2022)
Kelly received the Inaugural Innovation Fellowship to support her work in bridging academia and industry for therapeutic development. No information is available regarding student advising or additional grants beyond this fellowship.
Based at the Personalised Medicine Centre (formerly Centre for Molecular Medicine and Innovative Therapeutics), Kelly operates within a specialized research environment focused on molecular medicine and translational therapeutic strategies.